Toggle navigation
Home
Medical
Vaccine May Keep Melanoma in Remission 4 Years
26-1-2021
Medical
https://rss2.feedspot.com/https://www.adea.org/GoDental/Dental_Blogs.aspx?context=1332081966
127
Giving melanoma patients a "personalized" vaccine can prompt an anti-tumor immune response that lasts for years, an early study finds.
Share
Tweet
Pin it
+1
Read The Rest
at : https://rss2.feedspot.com/https://www.adea.org/GoDental/Dental_Blogs.aspx?context=1332081966
Related News
What To Expect From The Omicron Booster Shot: COVID...
US Now Among Countries Confirmed With Circulating...
Inhaled COVID-19 Vaccine Booster Gets Green Light In...
In Small Study, CAR-T Therapy Pushes Lupus Into Remission
Pediatricians Urge Flu Vaccine for Kids
CDC Gives Final Approval to Omicron COVID-19 Vaccine...
Celebrating 50 years of global dentistry innovation
Oral melanoma: a multicenter study of 69 patients from Japan
COVID-19 Vaccine Shot vs. Nasal Spray: Which Is Better?
Monkeypox Vaccine Maker Struggles To Meet Demand Amid...